Cellenkos, Inc.
Developing off-the-shelf T regulatory (Treg) cell therapies for rare inflammatory diseases and autoimmune disorders.
14 employees · est. 2016
Tr1X
Engineering cures for patients with autoimmune & inflammatory diseases.
46 employees · est. 2018 · San Diego, United States
Cellenkos, Inc. is the older company (2016 vs 2018).
Side-by-Side Comparison
| Metric | Cellenkos, Inc. | Tr1X |
|---|---|---|
| Founded | ||
| Founded | 2016 older | 2018 |
| Headquarters | ||
| Headquarters | Not tracked yet | San Diego, United States |
| Employees | ||
| Employees | 14 | 46 |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series A | Unknown |
| Total Funding | ||
| Total Funding | $15.00M | $125.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Development of T-Regulatory Cell Therapies, Clinical Trial Management, Allogeneic Therapy Research | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with Autoimmune Diseases, Healthcare Providers, Biotechnology Researchers, Pharmaceutical Companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Treg Cell Therapy, Allogeneic Products, Inflammatory Diseases, Autoimmune Disorders, CRANE Platform, Umbilical Cord Blood, Rare Autoimmune Blood Disorders, Cell Therapy, Immunomodulation, Oncology, Neuro-degenerative Diseases, Inflammatory Pulmonary Disease, MD Anderson Cancer Center, Clinical-Stage | Cellular Immunotherapies, Autoimmune Diseases, Inflammatory Diseases, Immune System, Cell Therapy, Proprietary Platform, Immune Modulation, Homeostasis, Tolerance, La Jolla, California |
| Website | ||
| Website | cellenkosinc.com | tr1x.bio |
About Cellenkos, Inc.
Cellenkos, Inc., established in 2016, is a clinical stage biotechnology company with a focus on developing off-the-shelf T regulatory (Treg) cell therapies for rare inflammatory and autoimmune diseases. Pioneered from a proprietary platform licensed from MD Anderson Cancer Center, Cellenkos leverage...
About Tr1X
Tr1X Inc. is a biotechnology company founded in 2018, with headquarters in La Jolla, CA. The company's slogan "Engineering cures for patients with autoimmune & inflammatory diseases" encapsulates its dedication to developing novel cellular immunotherapies for patients in need. Tr1X specializes in le...
We will tell you when either one moves
BounceWatch watches Cellenkos, Inc. and Tr1X for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Cellenkos, Inc. and Tr1X — by email.
Frequently Asked Questions
Compare Cellenkos, Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Cellenkos, Inc. on 2 Apr 2026, and Tr1X on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.